Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Ha, Chul-Won  [Clear All Filters]
Journal Article
Suh K, Cole BJ, Gomoll A, Lee S-M, Choi H, Ha C-W, Lim HChul, Kim MKu, Ha G-Y, Suh D-C. Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis. Appl Health Econ Health Policy. 2022.
Ha J-W, Kim J-A, Ha C-W. Do the Fibroblasts Contained in Early Passage MSC Population Adversely Affect the Characteristics of Stem Cell Population Obtained from Human Placenta?. Int J Stem Cells. 2012;5(2):89-95.
Park Y-B, Seo S, Kim J-A, Heo J-C, Lim Y-C, Ha C-W. Effect of chondrocyte-derived early extracellular matrix on chondrogenesis of placenta-derived mesenchymal stem cells. Biomed Mater. 2015;10(3):035014.
Kim J-A, An Y-H, Yim H-G, Han W-J, Park Y-B, Park HJin, Kim MYoung, Jang J, Koh RH, Kim S-H, et al. Injectable Fibrin/Polyethylene Oxide Semi-IPN Hydrogel for a Segmental Meniscal Defect Regeneration [Formula: see text]. Am J Sports Med. 2021:363546521998021.
Kim SHwan, Djaja YPratama, Park Y-B, Park J-G, Ko Y-B, Ha C-W. Intra-articular Injection of Culture-Expanded Mesenchymal Stem Cells Without Adjuvant Surgery in Knee Osteoarthritis: A Systematic Review and Meta-analysis. Am J Sports Med. 2019:363546519892278.
Ha C-W, Park Y-B. Mesenchymal Stem Cell Injection for Osteochondral Lesions of the Talus: Letter to the Editor. Am J Sports Med. 2014;42(6):NP34-NP35.
Ha C-W, Park Y-B, Min B-W, Han S-B, Lee JHyup, Won Y-Y, Park Y-S. Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis. J Ethnopharmacol. 2016.